SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,286 | +20.1% | 3,560 | +36.5% | 0.00% | – |
| Q2 2023 | $68,505 | +45.7% | 2,609 | +42.8% | 0.00% | – |
| Q1 2023 | $47,010 | -4.1% | 1,827 | -2.9% | 0.00% | – |
| Q4 2022 | $49,040 | -15.4% | 1,881 | -8.8% | 0.00% | – |
| Q3 2022 | $58,000 | +61.1% | 2,063 | +38.7% | 0.00% | – |
| Q2 2022 | $36,000 | -58.1% | 1,487 | -3.3% | 0.00% | – |
| Q1 2022 | $86,000 | -9.5% | 1,538 | -0.1% | 0.00% | – |
| Q4 2021 | $95,000 | +86.3% | 1,540 | +93.7% | 0.00% | – |
| Q3 2021 | $51,000 | +142.9% | 795 | +213.0% | 0.00% | – |
| Q2 2021 | $21,000 | +10.5% | 254 | 0.0% | 0.00% | – |
| Q1 2021 | $19,000 | – | 254 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |